Overview: Luxturna by Spark Therapeutics
An overview of RNAi therapies
Overview of Kymriah (CAR-T therapy) by Novartis in ALL
Overview of CAR-T therapies
Overview of the Prostate Cancer treatment landscape
Bladder cancer and immuno-oncology therapies
Outcomes-based contracting in the US pharmaceutical market
A snapshot of the Indian pharma industry
Multiple Sclerosis and the launch of Ocrevus
The Atopic Dermatitis market and the approval of Dupixent
The impact of Brexit on the pharmaceutical landscape of the United Kingdom
What’s the skinny behind the Repatha (Evolocumab) FOURIER trial results that were announced recently by Amgen?
